Personal information

health economics, outcomes research, pharmaceutical outcomes, HEOR, pharmacoepidemiology, real-world evidence, RWE

Biography

Mr. Sendhil is currently a senior analyst in the health economics and outcomes research (HEOR) practice at Analysis Group, Inc., and holds over four years of professional experience in the healthcare industry. He has a wide range of experience in HEOR and pharmacoepidemiology, including studies on causal methods. He has led analyses for real-world evidence (RWE) studies in several oncology and non-oncology settings, such as lung cancer, systemic mastocytosis, and hemophilia A. His experience includes retrospective claims database studies, chart review studies, systematic literature reviews, and post-hoc trial-based economic evaluations. Using a variety of epidemiological methods such as inverse probability of treatment weighting and propensity score analysis, he has examined treatment patterns, healthcare costs, resource utilization, and other patient outcomes. Mr. Sendhil’s RWE generation studies have been used to contextualize clinical trial results for regulatory submission in Europe. Additionally, he has published original research in peer-reviewed journals.

Activities

Education and qualifications (2)

University of California Los Angeles: Los Angeles, CA, US

B.S. (Statistics)
Education
Source: Self-asserted source
Selvam Sendhil

University of California Los Angeles: Los Angeles, CA, US

B.A. (Gender Studies)
Education
Source: Self-asserted source
Selvam Sendhil